Sentence examples for clinical power from inspiring English sources

Compared with their counterparts in Western societies, Czech physicians enjoyed more clinical power and professional authority over patients because of their status as civil servants (Heitlinger 1995).

Our study suggests a link between patient outcome and three-dimensional nuclear-telomere organization and highlights the potential clinical power of telomere signatures as a new prognostic, predictive, and potentially pharmacodynamic biomarker in GBM.

In June, Daniel Anderson and Tyler Jacks at MIT demonstrated the potential clinical power of CRISPR-Cas9 based CRISPR-Cas9 basedring a veditingo-expressing Cas9 and a guide RNA, plus a second DNA containing a repair template, into the tail veins of a mouse model of hereditary tyrosinemia type I, which is caused by a single point mutation in the fumarylacetoacetate hydeliveringne.

Further studies to examine the clinical power and utility of putative markers for autism, including those related to the immune response, are needed to help determine the usefulness in assisting early diagnosis of autism.

In contrast to Hospital A, the doctors did not use their clinical power to obstruct the change process, but accepted the new discharge arrangement: 'Well, I feel this [discharge arrangements] is part of us [the doctors?] now.

The negatives were considerable and included the Internet as a portal to threats of disorder, misinformation and numerous dangers, as well as raising concerns around professional roles, boundaries, medico-legal or ethical issues and clinical power.

The panel faced a barrage of questions from Greens senator Sarah Handon-Young and Labor senator Kim Carr about complaints from asylum seekers, incident reporting protocols, clinical depression, power failures and mould on tents in the island.

Clinical Relevance: Power and probe design have the greatest influence among the factors tested; selecting these parameters preoperatively could control tissue effect.

Cancer cell lines have proven successful drug discovery tools in the past, yet they have recognized limitations, specifically the lack of clinical predictive power owing to their restricted capacity to recapitulate cancer's diversity.

Further studies involving a larger number of patients are warranted, in order to determine the full clinical discriminatory power of this diagnostic tool.

Activation of stem cell genes was interrogated across different breast cancer cohorts and within specific subtypes and tested for clinical prognostic power.